- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Medical Equipment/Devices
- Sub-Industry: Life Science Equipment
Illumina Inc+ Add to Watchlist
ILMN:US71.6900 USD 1.0700 1.52%
As of 20:10:00 ET on 06/18/2013.
Company Profile for Illumina Inc (ILMN)
Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
Key Executives for Illumina Inc (ILMN)
|Jay T FlatleyPresident/CEO||Marc A StapleySenior VP/CFO|
|Mostafa RonaghiSenior VP/CTO||Tristan B OrpinSenior VP/Chief Commercial Ofcr|
|Charles E DadswellSenior VP/Secy/General Counsel||Gregory F HeathSenior VP/Gen Mgr:Diagnostics|
|Christian O HenrySenior VP/Gen Mgr:Genomic Systems||Mark L LewisSenior VP/Gen Mgr: Molecular|
|Matthew L PosardSenior VP/Gen Mgr:Translational||Nicholas J Naclerio "Nick"Senior VP:Corporate|
|Paul BianchiSenior VP:Human Resources||Rebecca ChambersSenior Dir:Investor Relations|